Intermittent fasting reduces alpha-synuclein pathology and functional decline in a mouse model of Parkinson’s disease
Abstract Parkinson’s disease (PD) is a neurodegenerative disorder characterized by dopaminergic neuron degeneration and α-synuclein (aSyn) accumulation. Environmental factors play a significant role in PD progression, highlighting the potential of non-pharmacological interventions. This study invest...
Saved in:
| Main Authors: | Éva M. Szegő, Lennart Höfs, Anna Antoniou, Elisabeth Dinter, Nadine Bernhardt, Anja Schneider, Donato A. Di Monte, Björn H. Falkenburger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-59249-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recursive seed amplification detects distinct α-synuclein strains in cerebrospinal fluid of patients with Parkinson’s disease
by: Stefan Bräuer, et al.
Published: (2025-01-01) -
A brain-penetrant bispecific antibody lowers oligomeric alpha-synuclein and activates microglia in a mouse model of alpha-synuclein pathology
by: Dag Sehlin, et al.
Published: (2025-03-01) -
Mitochondrial oxidant stress promotes α-synuclein aggregation and spreading in mice with mutated glucocerebrosidase
by: Pietro La Vitola, et al.
Published: (2024-12-01) -
Determinants of alpha-synuclein pathogenesis in Parkinson’s disease
by: Oriol Bárcenas, et al.
Published: (2026-04-01) -
Alpha-Synuclein Dysregulation in Systemic Pathophysiology of Synucleinopathies
by: Hallie H. Dolin, et al.
Published: (2025-07-01)